The I.M. Rosenzweig Junior Investigator Award Winners​

The I.M. Rosenzweig Junior Investigator Award was established to encourage researchers to maintain and enhance their interest in PF research during the early stages of their academic career. 

The Albert Rose Established Investigator Award Winners

Created to allow established investigators to explore novel, innovative areas of research, the Albert Rose Established Investigator Award provides critical support to the development of new projects, and enables the investigator to pursue additional funding through the National Institutes of Health or other agencies. Two $50,000 grants are awarded per annual cycle, disbursed over a two-year period.

Chiko Shimbori, PhD

Apr 19, 2021, 16:31 PM
Title : Chiko Shimbori, PhD
First Name : Chiko
Middle Name :
Last Name : Shimbori, PhD
Position :
University :
Proposal Title : "The Role of Mast Cells in Pathophysiology of Pulmonary Fibrosis"
Proposal Funder : InterMune, Inc.
Originally from Japan, she received BS and MS degrees at Tottori University. She earned a PhD from Shimane University in the Department of Medicine and Pharmacology in Japan. Dr. Shimbori currently conducts research under Dr. Martin Kolb at McMaster University in the area of pulmonary fibrosis.

Through her doctoral and post-doctoral training, Dr. Shimboris learned that the tissue microenvironment is a crucial element in pulmonary fibrosis and can substantially influence the characteristics, activity, and differentiation of cells. Her current research focus is on mast cells and their role in the disease. Amongst others, she explores the impact of the extracellular matrix in idiopathic pulmonary fibrosis (IPF) on mast cell function and characteristics. In particular, she investigates the role of mast cells as profibrotic elements-- not their well-known inflammatory properties. Dr. Shimboris believes that her studies will help scientists better understand some of the mechanisms that cause the progression of pulmonary fibrosis and thereby lead to the development of new therapies for IPF.

Dr. Shimbori enjoys working with her wonderful supervisor and colleagues and life in Canada. She also loves nature and relaxes by practicing yoga.